|
TMEM109 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62625468647093E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62481139653892E-12 |
| Normal-vs-Stage2 |
6.0797000001056E-07 |
| Normal-vs-Stage3 |
1.55799000000068E-05 |
| Normal-vs-Stage4 |
3.157900E-02 |
| Stage1-vs-Stage2 |
9.867400E-01 |
| Stage1-vs-Stage3 |
1.364810E-01 |
| Stage1-vs-Stage4 |
9.396600E-01 |
| Stage2-vs-Stage3 |
2.824800E-01 |
| Stage2-vs-Stage4 |
9.374000E-01 |
| Stage3-vs-Stage4 |
6.478400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
3.11019987542238E-10 |
| Normal-vs-Asian |
8.141500E-02 |
| Caucasian-vs-AfricanAmerican |
3.913600E-02 |
| Caucasian-vs-Asian |
7.050200E-01 |
| AfricanAmerican-vs-Asian |
7.434400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
9.85360004701619E-09 |
| Male-vs-Female |
3.719100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.30430002751336E-09 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
2.12609996275148E-09 |
| Normal-vs-Extreme_Obese |
2.96385138653932E-12 |
| Normal_Weight-vs-Extreme_Weight |
4.283000E-01 |
| Normal_Weight-vs-Obese |
2.931200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.112440E-02 |
| Extreme_Weight-vs-Obese |
2.246300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.169600E-02 |
| Obese-vs-Extreme_Obese |
7.222100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.403410E-03 |
| Normal-vs-Age(41-60Yrs) |
5.41677813714614E-13 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
7.64790000218341E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.488200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.603900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.381200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.241580E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.070800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.825600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11022302462516E-16 |
| Normal-VS-Type2 PRCC |
8.99280649946377E-15 |
| Normal-VS-KIRP CIMP |
3.728800E-01 |
| Normal-VS-Unclassified PRCC |
4.89239999956759E-07 |
| Type1 PRCC-VS-Type2 PRCC |
9.760600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.693050E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.444790E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.725620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.870440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.458000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62558855265615E-12 |
| Normal-vs-N1 |
2.40789999998992E-05 |
| Normal-vs-N2 |
7.848200E-01 |
| N0-vs-N1 |
9.523900E-02 |
| N0-vs-N2 |
3.759800E-01 |
| N1-vs-N2 |
5.352400E-01 |
|
|
